Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

5,650.00p
   
  • Change Today:
      40.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 3,744.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 120,490
  • Market Cap: £3,715.78m
  • RiskGrade: 128

Genus Overview

Genus applies science to animal breeding. Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors. It is a provider of bovine genetics and reproduction services, marketing in more than 70 countries.
Registrars: Equiniti

Key Personnel

Non-Executive Chairman: Iain Ferguson
CEO: Stephen Wilson
CFO: Alison Henriksen
Independent Non-Executive Director: Lykele van der Broek
Independent Non-Executive Director: Lysanne Gray
Senior Independent Director: Lesley Knox
Non-Executive Dir: Jason Chin

Contact Details

Address: Matrix House, Basing View, Basingstoke, Hampshire, United Kingdom, RG21 4DZ
Phone: +44 (0) 1256 347 100
Fax: +44 (0) 1256 477 385
Website: http://www.genusplc.com

Listings

Sector: Pharma and Biotech(LSE)
Index: techMARKFTSE 250FTSE 350FTSE All-ShareFTSE techMARK Focus
Overseas Listings: BATSLON:GNSL
ISIN: GB0002074580

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 5,650.00p
Change Today 40.00p
% Change 0.71 %
52 Week High 6,070.00
52 Week Low 3,744.00
Volume 120,490
Shares Issued 65.77m
Market Cap £3,715.78m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.62% below the market average99.62% below the market average99.62% below the market average99.62% below the market average99.62% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
63.01% above the market average63.01% above the market average63.01% above the market average63.01% above the market average63.01% above the market average
51.61% above the sector average51.61% above the sector average51.61% above the sector average51.61% above the sector average51.61% above the sector average
Income
63.89% below the market average63.89% below the market average63.89% below the market average63.89% below the market average63.89% below the market average
63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average
Growth
84.04% above the market average84.04% above the market average84.04% above the market average84.04% above the market average84.04% above the market average
61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 6
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 18-Nov-21 04-Mar-21
Paid 10-Dec-21 01-Apr-21
Amount 21.70p 10.30p

Trades for 17-Sep-2021

Time Volume / Share Price
16:45 74 @ 5,655.00p
16:45 74 @ 5,655.00p
16:36 1,250 @ 5,650.00p
16:35 65,811 @ 5,650.00p
16:29 5 @ 5,650.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page